Noninfectious Dermatoses of the Vulva

  • Boštjan Luzar
  • Eduardo Calonje
Part of the Essentials of Diagnostic Gynecological Pathology book series (EDGP)


This chapter covers inflammatory dermatoses that affect the vulva primarily or secondarily in association with cutaneous or mucosal involvement elsewhere as well as the most common inflammatory systemic diseases that affect this organ. Each entity is outlined according to its definition, clinical features, most relevant epidemiological and demographical data, and pathogenesis where relevant. Defining histological features are detailed, with special emphasis given to the morphological diversity of the lesions at this particular location as a result of dampness, occlusion, and friction. Description of the entity is finally completed by the discussion of the most relevant differential diagnoses, whenever deemed necessary.


Lichen Planus Bullous Pemphigoid Reactive Arthritis Inflammatory Cell Infiltrate Lichen Sclerosus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Tappeiner J, Pfleger L. Granuloma gluteale infantum. Hautarzt. 1971;22:383–8.PubMedGoogle Scholar
  2. 2.
    Bazex A, Dupre A, Christol B, et al. Infantile gluteal granuloma (Tappeiner and Pfleger). Should it be considered as ‘contact vegetating fluorides’ or as ‘infant halogenosis’. Ann Dermatol Syphiligr (Paris). 1972;99:121–33.Google Scholar
  3. 3.
    Strögmann W. Gluteal granuloma of infants. A new (detergent-induced?) infantile dermatosis. Monatsschr Kinderheilkd. 1974;122:665–6.Google Scholar
  4. 4.
    Lovell CR, Atherton DJ. Infantile gluteal granuloma – case report. Clin Exp Dermatol. 1984;9:522–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Valli F, Della Morte MA, Meschi V, et al. Infantile gluteal granuloma. Case report. Pediatr Med Chir. 1985;7:137–9.PubMedGoogle Scholar
  6. 6.
    Delacretaz J, Grigoriu D, de Crousaz H, et al. Nodular candidiasis of the inguino-genital and gluteal region (granuloma gluteale infantum). Dermatologica. 1972;144:143–55.PubMedGoogle Scholar
  7. 7.
    Bonifazi E, Garofalo L, Lospalluti M, et al. Granuloma gluteale infantum with atrophic scars: clinical and histological observations in eleven cases. Clin Exp Dermatol. 1981;6:23–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Bourrat E, Vaquin C, Prigent F, et al. Perianal papulonodular dermatitis in Hirschsprung disease. Ann Dermatol Venereol. 1996;123:549–51.PubMedGoogle Scholar
  9. 9.
    Rodriguez-Poblador J, Gonzalez-Castro U, Herranz-Martinez S, et al. Jacquet erosive dermatitis after surgery for Hirschsprung disease. Pediatr Dermatol. 1998;15:46–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Virgili A, Corazza M. Sevestre et Jacquet. Ann Dermatol Venereol. 1992;119:744–5.PubMedGoogle Scholar
  11. 11.
    Virgili A, Corazza M, Califono A. Diaper dermatitis in an adult. A case of erythema papuloerosive of Sevestre and Jacquet. J Reprod Med. 1998;43:949–51.PubMedGoogle Scholar
  12. 12.
    Fujita M, Ohno S, Danno K, et al. Two cases of diaper area granuloma of the adult. J Dermatol. 1991;18:671–5.PubMedGoogle Scholar
  13. 13.
    Maekawa Y, Sakazaki Y, Hayashibara T. Diaper area granuloma of the aged. Arch Dermatol. 1978;114:382–3.PubMedCrossRefGoogle Scholar
  14. 14.
    McKee PH, Calonje E, Granter SR. Spongiotic, psoriasiform and pustular dermatoses. In: McKee PH, Calonje E, Granter SR, editors. Pathology of the skin with clinical correlations. 3rd ed. Philadelphia: Elsevier Mosby; 2005. p. 171–216.Google Scholar
  15. 15.
    Fischer GO. The commonest causes of symptomatic vulvar disease: a dermatologist’s perspective. Australas J Dermatol. 1996;37:12–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Crone AM, Stewart EJC, Wojnarowska F, et al. Aetiological factors in vulvar dermatitis. J Eur Acad Dermatol Venereol. 2000;14:181–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Fisher G, Spurret B, Fisher A. The chronically symptomatic vulva: aetiology and management. Br J Obstet Gynaecol. 1995;102:773–9.CrossRefGoogle Scholar
  18. 18.
    Niamh L, Naveen S, Hazel B. Diagnosis of vulval inflammatory dermatoses: a pathological study with clinical correlation. Int J Gynecol Pathol. 2009;28:554–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Cheung ST, Gach JE, Lewis FM. A retrospective study of the referral patterns to a vulval clinic: highlighting educational needs in this subspecialty. J Obstet Gynaecol. 2006;26:435–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Ball SB, Wojnarowska F. Vulvar dermatoses: lichen sclerosus, lichen planus, and vulval dermatitis/lichen simplex chronicus. Semin Cutan Med Surg. 1998;17:182–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Bowen AR, Vester A, Marsden L, et al. The role of vulvar skin biopsy in the evaluation of chronic vulvar pain. Am J Obstet Gynecol. 2008;199:467.e1–e6.CrossRefGoogle Scholar
  22. 22.
    O’Keefe RJ, Scurry JP, Dennerstein G, et al. Audit of 114 non-neoplastic vulvar biopsies. Br J Obstet Gynaecol. 1995;102:780–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Margesson LJ. Contact dermatitis of the vulva. Dermatol Ther. 2004;17:20–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Johansson SGO, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113:832–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Wakashin K. Sanitary napkin contact dermatitis of the vulva: location-dependent differences in skin surface conditions may play a role in negative patch test results. J Dermatol. 2007;34:834–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Hammock LA, Barret TL. Inflammatory dermatoses of the vulva. J Cutan Pathol. 2005;32:604–11.PubMedCrossRefGoogle Scholar
  27. 27.
    Eiermann HJ, Larsen W, Maibach HI, et al. Prospective study of cosmetic reactions: 1977–1980. North American Contact Dermatitis Group. J Am Acad Dermatol. 1982;6:909–17.PubMedCrossRefGoogle Scholar
  28. 28.
    Faergemann J, Bergbrant IM, Dohsé M, et al. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol. 2001;144:549–56.PubMedCrossRefGoogle Scholar
  29. 29.
    Williams HC. Diagnostic criteria for atopic dermatitis. Where do we go from here? Arch Dermatol. 1999;135:583–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Fischer G, Rogers M. Vulvar disease in children: a clinical audit of 130 children. Pediatr Dermatol. 2000;17:1–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Taylor RM. Histopathology of contact dermatitis. Clin Dermatol. 1986;4:18–22.PubMedCrossRefGoogle Scholar
  32. 32.
    White Jr CR. Histopathology of atopic dermatitis. Semin Dermatol. 1983;2:234–8.Google Scholar
  33. 33.
    White CR. Histopathology of exogenous and systemic contact dermatitis. Semin Dermatol. 1990;9:226–9.PubMedGoogle Scholar
  34. 34.
    Shaffer B, Beerman H. Lichen simplex chronicus and its variants: discussion of certain psychodynamic mechanisms and clinical and histopathologic correlations. AMA Arch Derm Syphilol. 1951;64:340–51.PubMedCrossRefGoogle Scholar
  35. 35.
    Lynch PJ. Lichen simplex chronicus (atopic/neurodermatitis) of the anogenital region. Dermatol Ther. 2004;17:8–19.PubMedCrossRefGoogle Scholar
  36. 36.
    Sullivan AK, Straughair GJ, Marwood RP, et al. A multidisciplinary vulva clinic: the role of genito-urinary medicine. J Eur Acad Dermatol Venereol. 1999;13:36–40.PubMedCrossRefGoogle Scholar
  37. 37.
    Rajalakshmi R, Trappa DM, Jainsankar TJ, et al. Lichen simplex chronicus of anogenital region: a clinic-etiological study. Indian J Dermatol Venereol Leprol. 2011;77:28–36.PubMedCrossRefGoogle Scholar
  38. 38.
    Rowland Payne CM, Wilkinson JD, McKee PH, et al. Nodular prurigo – a clinicopathological study of 46 patients. Br J Dermatol. 1985;113:431–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Gach JE, Seddon HF. Gluten-sensitive enteropathy associated with genital lichen simplex chronicus. JRSM Short Rep. 2010;1:43–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Hallopeau H. Lichen plan sclereux. Ann Dermatol Syph (2nd Ser). 1889;20:447–9.Google Scholar
  41. 41.
    Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol. 1995;32:393–416.PubMedCrossRefGoogle Scholar
  42. 42.
    Attili VR, Attili SK. Lichen sclerosus of lips: a clinical and histopathological study of 27 cases. Int J Dermatol. 2010;49:520–5.PubMedCrossRefGoogle Scholar
  43. 43.
    Ballester I, Banuls J, Perez-Crespo M, et al. Extragenital bullous lichen sclerosus atrophicus. Dermatol Online J. 2009;1:6.Google Scholar
  44. 44.
    Aggarwal K, Jain VK, Brahma D. Palmo-plantar lichen sclerosus et atrophicus. Indian J Dermatol Venereol Leprol. 2003;69:43–4.PubMedGoogle Scholar
  45. 45.
    Sherlin HJ, Ramalingam K, Natesan A, et al. Lichen sclerosus of the oral cavity. Case report and review of the literature. J Dermatol Case Rep. 2010;3:38–43.Google Scholar
  46. 46.
    Saunders H, Buchanan JAG, Cooper S, et al. The period prevalence of oral lichen planus in a cohort of patients with wulvar lichen sclerosus. J Eur Acad Dermatol Venereol. 2009;24:18–21.PubMedCrossRefGoogle Scholar
  47. 47.
    Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet. 1999;353:1777–83.PubMedCrossRefGoogle Scholar
  48. 48.
    Barbagli G, Mirri F, Gallucci M, et al. Histological evidence of urethral involvement in male patients with genital lichen sclerosus: a preliminary report. J Urol. 2011;185:2171–6.PubMedCrossRefGoogle Scholar
  49. 49.
    Kimura A, Kambe N, Satoh T, et al. Follicular keratosis and bullous formation are typical signs of extragenital lichen sclerosus. J Dermatol. 2010;38:834–6.PubMedCrossRefGoogle Scholar
  50. 50.
    Ristić B, Divic J, Belic LJ, et al. Bullous lichen sclerosus atrophicus. J Eur Acad Dermatol Venereol. 2004;18:99–117.CrossRefGoogle Scholar
  51. 51.
    Tasker GL, Wojnarowska F. Lichen sclerosus. Clin Exp Dermatol. 2003;28:128–33.PubMedCrossRefGoogle Scholar
  52. 52.
    Sherman V, McPherson T, Baldo M, et al. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J Eur Acad Dermatol Venereol. 2010;24:1031–4.PubMedGoogle Scholar
  53. 53.
    Powel JJ, Wojnarowska F, Winsey S, et al. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol. 2000;142:481–4.CrossRefGoogle Scholar
  54. 54.
    Marren P, Yell J, Charnock FM, et al. The association between lichen sclerosus and the HLA system. Br J Dermatol. 1995;132:197–203.PubMedCrossRefGoogle Scholar
  55. 55.
    Azurdia RM, Luzzi GA, Byren I, et al. Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease. Br J Dermatol. 1999;140:79–83.PubMedCrossRefGoogle Scholar
  56. 56.
    Aslanian FMNP, Marques MTQ, Matos HJ, et al. HLA markers in familial lichen sclerosus. J Dtsch Dermatol Ges. 2006;4:842–7.PubMedCrossRefGoogle Scholar
  57. 57.
    Meyrick Thomas RH, Ridley CM, McGibbon DH, et al. Lichen sclerosus et atrophicus and autoimmunity: a study of 350 women. Br J Dermatol. 1988;118:41–6.PubMedCrossRefGoogle Scholar
  58. 58.
    Cooper S, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease. A case-control study. Arch Dermatol. 2008;144:1432–5.PubMedCrossRefGoogle Scholar
  59. 59.
    Kim DH, Lee KR, Kim TY, et al. Coexistence of lichen sclerosus with morphea showing bilateral symmetry. Clin Exp Dermatol. 2009;34:416–8.CrossRefGoogle Scholar
  60. 60.
    Goolamali SI, Neill SM. A first case of lichen sclerosus with Turner’s syndrome. Clin Exp Dermatol. 2009;34:419–20.CrossRefGoogle Scholar
  61. 61.
    Zollinger T, Mertz KD, Schmid M, et al. Borrelia in granuloma annulare, morphea and lichen sclerosus: a PCR-based study and review of the literature. J Cutan Pathol. 2010;37:571–7.PubMedCrossRefGoogle Scholar
  62. 62.
    McPherson T, Cooper S. Vulvar lichen sclerosus and lichen planus. Dermatol Ther. 2010;523:532.Google Scholar
  63. 63.
    Carlson JA, Ambros R, Malfetano J, et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum Pathol. 1998;29:239–48.CrossRefGoogle Scholar
  64. 64.
    Wang S-H, Chi C-C, Wong YW, et al. Genital verrucous carcinoma is associated with lichen sclerosus: a retrospective study and review of the literature. J Eur Acad Dermatol Venereol. 2010;24:815–9.PubMedCrossRefGoogle Scholar
  65. 65.
    Serheant A, Vernall N, Mackintosh LJ, et al. Squamous cell carcinoma arising in extragenital lichen sclerosus. Clin Exp Dermatol. 2009;34:278–9.CrossRefGoogle Scholar
  66. 66.
    Regauer S, Liegl B, Reich O. Early vulvar lichen sclerosus: a histopathological challenge. Histopathology. 2005;47:340–7.PubMedCrossRefGoogle Scholar
  67. 67.
    Slater DN, Wagner BE. Early vulvar lichen sclerosus: a histopathological challenge. Histopathology. 2007;50:388–9.PubMedCrossRefGoogle Scholar
  68. 68.
    Uitto J, Santa Cruz DJ, Bauer EA, et al. Morphea and liche sclerosus et atrophicus. Clinical and histologic studies in patients with combined features. J Am Acad Dermatol. 1980;3:271–9.PubMedCrossRefGoogle Scholar
  69. 69.
    Rakha E, Mayne C, Brown L. Mucinous metaplasia of the vulva in a case of lichen sclerosus. A case report. J Clin Pathol. 2005;58:1217–8.PubMedCrossRefGoogle Scholar
  70. 70.
    Regauer S, Beham-Schmid C. Detailed analysis of the T-cell lymphocytic infiltrate in penile lichen sclerosus: an immunohistochemical and molecular investigation. Histopathology. 2006;48:730–5.PubMedCrossRefGoogle Scholar
  71. 71.
    Regauer S, Liegl B, Reich O, et al. Vasculitis in lichen sclerosus: an under recognized feature? Histopa­thology. 2004;45:237–44.PubMedCrossRefGoogle Scholar
  72. 72.
    Luzar B, Neil SM, Calonje E. Angiokeratoma-like changes in extragenital and genital lichen sclerosus. J Cutan Pathol. 2009;36:540–2.PubMedCrossRefGoogle Scholar
  73. 73.
    Dargent J-L. Acquired lymphangiectasias in genital lichen sclerosus. Am J Dermatopathol. 2011;33:200–2.PubMedCrossRefGoogle Scholar
  74. 74.
    Abbas O, Chatrath V, Goldberg LJ. Elastophagocytosis in extragenital lichen sclerosus. J Cutan Pathol. 2010;37:1032–7.PubMedCrossRefGoogle Scholar
  75. 75.
    Suchak R, Verdolini R, Robson A, et al. Extragenital lichen sclerosus et atrophicus mimicking cutaneous T-cell lymphoma: report of a case. J Cutan Pathol. 2010;37:982–6.PubMedCrossRefGoogle Scholar
  76. 76.
    Perera E, Toll A, Gallardo F, et al. Lichen sclerosus et atrophicus-like lesions in mycosis fungoides. Br J Dermatol. 2007;157:411–3.CrossRefGoogle Scholar
  77. 77.
    Meeuwis KA, De Hullu JA, de Jager MEA, et al. Genital psoriasis: a questionnaire-based survey on a concealed skin disease in the Netherlands. J Eur Acad Dermatol Venereol. 2010;24:1425–30.PubMedCrossRefGoogle Scholar
  78. 78.
    Meeuwis KA, de Hullu JA, Massuger LF, et al. Genital psoriasis: a systematic review on this hidden skin disease. Acta Derm Venereol. 2011;91:5–11.PubMedGoogle Scholar
  79. 79.
    Farber EM, Nall ML. The natural history of psoriasis in 5600 patients. Dermatologica. 1974;148:1–18.PubMedCrossRefGoogle Scholar
  80. 80.
    Zamirska A, Reich A, Berny-Moreno J, et al. Vulvar pruritus and burning sensation in women with psoriasis. Acta Derm Venereol. 2008;88:132–5.PubMedCrossRefGoogle Scholar
  81. 81.
    Gross G. Dermatologische befunde an Mamma und Genitale. Der Gynakologe. 2001;34:940–8.CrossRefGoogle Scholar
  82. 82.
    Porter WM, Bunker CB. The dysfunctional foreskin. Int J STD AIDS. 2001;12:216–20.PubMedCrossRefGoogle Scholar
  83. 83.
    Quan MB, Ruben BS. Pustular psoriasis limited to the penis. Int J Dermatol. 1996;35:202–4.PubMedCrossRefGoogle Scholar
  84. 84.
    Singh N, Thappa DM. Circinate pustular psoriasis localized to glans penis mimicking ‘circinate balanitis’ and responsive to dapsone. Indian J Dermatol Venereol Leprol. 2008;74:388–9.PubMedCrossRefGoogle Scholar
  85. 85.
    Scully G, El-Kom M. Lichen planus: review and update on pathogenesis. J Oral Pathol. 1985;14:431–58.PubMedCrossRefGoogle Scholar
  86. 86.
    Belifore P, Di Fede O, Cabibi D, et al. Prevalence of vulval lichen planus in a cohort of women with oral lichen planus: an interdisciplinary study. Br J Dermatol. 2006;155:994–8.CrossRefGoogle Scholar
  87. 87.
    Eisen D. The clinical manifestations and treatment of oral lichen planus. Dermatol Clin. 2003;21:79–89.PubMedGoogle Scholar
  88. 88.
    Lewis FM, Shah M, Harrington CI. Vulval involvement in lichen planus: a study of 37 women. Br J Dermatol. 1996;135:89–91.PubMedCrossRefGoogle Scholar
  89. 89.
    Micheletti L, Preti M, Bogliatto F, et al. Vulval lichen planus in the practice of vulval clinic. Br J Dermatol. 2000;143:1349–50.PubMedCrossRefGoogle Scholar
  90. 90.
    Eisen D. The clinical features, malignant potential and systemic association of oral lichen planus: a study of 723 patients. J Am Acad Dermatol. 2002;46:207–14.PubMedCrossRefGoogle Scholar
  91. 91.
    Pelisse M, Leibowitch M, Sedel D, et al. Un nouveau syndrome vulvo-vaginal gingival: lichen planus erosive plurimuqueux. Ann Dermatol Venereol. 1982;109:797–8.PubMedGoogle Scholar
  92. 92.
    Helgersen ALO, Gjersvik P, Jebsen P, et al. Vaginal involvement in genital erosive lichen planus. Acta Obstet Gynecol Scand. 2010;89:966–70.CrossRefGoogle Scholar
  93. 93.
    Kennedy CM, Galask RP. Erosive vulvar lichen planus: retrospective review of characteristics and outcomes in 113 patients seen in a vulvar specialty clinic. J Reprod Med. 2007;52:43–7.PubMedGoogle Scholar
  94. 94.
    Gupta R, Bansal B, Singh S, et al. Lichen planus of the uterine cervix – the first report of a novel site of occurrence: a case report. Cases J. 2009;2:9306–8.PubMedCrossRefGoogle Scholar
  95. 95.
    Goldstein AT, Metz A. Vulvar lichen planus. Clin Obstet Gynecol. 2005;48:818–23.PubMedCrossRefGoogle Scholar
  96. 96.
    Cooper SM. Influence of treatment of erosive lichen planus of the vulva and its prognosis. Arch Dermatol. 2006;142:289–94.PubMedCrossRefGoogle Scholar
  97. 97.
    Cooper SM, Ali I, Baldo M, et al. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease. Arch Dermatol. 2008;144:1432–5.PubMedCrossRefGoogle Scholar
  98. 98.
    Moutasim KA, Poate TWJ, Setterfield JF, et al. A case of vulvovaginal gingival lichen planus in association with Good’s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:57–60.Google Scholar
  99. 99.
    Lewis FM. Vulval lichen planus. Br J Dermatol. 1998;138:569–75.PubMedCrossRefGoogle Scholar
  100. 100.
    Dwyer CM, Kerr REI, Millan DWM. Squamous carcinoma following lichen planus of the vulva. Clin Exp Dermatol. 1995;20:171–2.PubMedCrossRefGoogle Scholar
  101. 101.
    Franck JM, Young AW. Squamous cell carcinoma arising within lichen planus of the vulva. Dermatol Surg. 1995;21:890–4.PubMedCrossRefGoogle Scholar
  102. 102.
    Jones RW, Rowan DM, Kirker J, et al. Vulval lichen planus: progression of pseudoepitheliomatous hyperplasia to invasive vulval carcinomas. BJOG. 2001;108:665–6.PubMedCrossRefGoogle Scholar
  103. 103.
    Chiu TL, Jones RW. Multicentric multifocal squamous cell carcinomas arising in vulvovaginal lichen planus. J Low Genit Tract Dis. 2011;15:246–7.PubMedCrossRefGoogle Scholar
  104. 104.
    Zoon JJ. Chronic circumscribed balanitis with plasma cells infiltration. Ned Tijdschr Geneeskd. 1950;94:1529–30.PubMedGoogle Scholar
  105. 105.
    Garnier G. Vulvite erythemateuse circonscrite benigne a type erythroplasique. Bull Soc Fr Dermatol Syphiligr. 1954;61:102–4.PubMedGoogle Scholar
  106. 106.
    Zoon JJ. Balanitis and vulvitis plasmacellularis. Dermatologica. 1955;11:157.Google Scholar
  107. 107.
    Fernandez-Aceñero MJ, Cordova S. Zoon’s vulvitis (vulvitis circumscripta plasmacellularis). Arch Gynecol Obstet. 2010;282:351–2.PubMedCrossRefGoogle Scholar
  108. 108.
    Li Q, Leopold K, Carlson JA. Chronic vulvar purpura: persistent pigmented purpuric dermatitis (lichen aureus) of the vulva or plasma cell (Zoon’s) vulvitis? J Cutan Pathol. 2003;30:572–6.PubMedCrossRefGoogle Scholar
  109. 109.
    Neri I, Patrizi A, Marzaduri S, et al. Vulvitis plasmacellularis: two new cases. Genitourin Med. 1995;71:311–3.PubMedGoogle Scholar
  110. 110.
    Bharti R, Smith DR. Mucous membrane plasmacytosis: a case report and review of the literature. Dermatol Online J. 2003;9:15.PubMedGoogle Scholar
  111. 111.
    White Jr JW, Olsen KD, Banks PM. Plasma cell orificial mucositis. Report of a case and review of the literature. Arch Dermatol. 1986;122:1321–4.PubMedCrossRefGoogle Scholar
  112. 112.
    Kato T, Kuramoto Y, Tadaki T, et al. Chronic vulvar purpura. Dermatologica. 1990;180:174–6.PubMedCrossRefGoogle Scholar
  113. 113.
    Thomson MA, Carr RA, Ganesan R, et al. Extensive mucinous metaplasia of the vulva arising in Zoon’s vulvitis. Br J Dermatol. 2007;156:750–2.PubMedCrossRefGoogle Scholar
  114. 114.
    Coghill SB, Tyler X, Shaxted EJ. Benign mucinous metaplasia of the vulva. Histopathology. 1990;17:373–5.PubMedGoogle Scholar
  115. 115.
    Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis. JAMA. 1932;99:1323–9.CrossRefGoogle Scholar
  116. 116.
    Burgdorf W. Cutaneous manifestations of Crohn’s disease. J Am Acad Dermatol. 1981;5:689–95.PubMedCrossRefGoogle Scholar
  117. 117.
    Schrodt BJ, Callen JP. Metastatic Crohn’s disease presenting as chronic perivulvar and perirectal ulcerations in an adolescent patient. Pediatrics. 1999;103:500–2.PubMedCrossRefGoogle Scholar
  118. 118.
    Palamaras I, El-Jabbour J, Pietropaolo N, et al. Metastatic Crohn’s disease: a review. J Eur Acad Dermatol Venereol. 2008;22:1033–43.PubMedCrossRefGoogle Scholar
  119. 119.
    Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976;55:401–12.CrossRefGoogle Scholar
  120. 120.
    Rankin GB, Watts HD, Melnyk CS, et al. National cooperative Crohn’s disease study: extraintestinal manifestations and perianal complications. Gastroenterology. 1979;77:914–20.PubMedGoogle Scholar
  121. 121.
    De la Poza G, Lopez-Sanroman A, Taxonera C, et al. Genital fistulas in female Crohn’s disease patients. Clinical characteristics and response to therapy. J Crohns Colitis. 2012;6:276–80.PubMedCrossRefGoogle Scholar
  122. 122.
    Andreani SM, Ratnasingham K, Dang HH, et al. Crohn’s disease of the vulva. Int J Surg. 2010;8:2–5.PubMedCrossRefGoogle Scholar
  123. 123.
    Galbraith SS, Drolet BA, Kugathasan S, et al. Asymptomatic inflammatory bowel disease presenting with mucocutaneous findings. Pediatrics. 2005;116:439–44.CrossRefGoogle Scholar
  124. 124.
    Vaid RM, Cohen BA. Cutaneous Crohn’s disease in the pediatric population. Pediatr Dermatol. 2010;27:279–81.PubMedCrossRefGoogle Scholar
  125. 125.
    Ploysangam T, Heubi JE, Eisen D, et al. Cutaneous Crohn’s disease in children. J Am Acad Dermatol. 1997;36:697–704.PubMedCrossRefGoogle Scholar
  126. 126.
    Savino A, Pelliccia P, Breda L, et al. Genital swelling in an adolescent patient. Eur J Pediatr. 2006;165:76–9.PubMedCrossRefGoogle Scholar
  127. 127.
    Guest MB, Fink RL. Metastatic Crohn’s disease. Dis Colon Rectum. 2000;43:1764–6.PubMedCrossRefGoogle Scholar
  128. 128.
    Günthert AR, Hinney B, Nesselhut K, et al. Vulvitis granulomatosa and unilateral hypertrophy of the vulva related to Crohn’s disease: a case report. Am J Obstet Gynecol. 2004;191:1719–20.PubMedCrossRefGoogle Scholar
  129. 129.
    Paradisi A, Diociaiuti A, Marchesi A, et al. Cutaneous Crohn disease mimicking anal condyloma in a child. J Am Acad Dermatol. 2010;63:165–6.PubMedCrossRefGoogle Scholar
  130. 130.
    Lestre S, Ramos J, Joao A, et al. Cutaneous Crohn’s disease presenting as genital warts: successful treatment with adalimumab. Eur J Dermatol. 2010;20:504–5.PubMedGoogle Scholar
  131. 131.
    Lockhart-Mummery HE. Symposium. Crohn’s disease: anal lesions. Dis Colon Rectum. 1975;18:200–2.PubMedCrossRefGoogle Scholar
  132. 132.
    Fielding JF. Perianal lesions in Crohn’s disease. J R Coll Surg Edinb. 1972;17:32–7.PubMedGoogle Scholar
  133. 133.
    McClane SJ, Rombeau JL. Anorectal Crohn’s disease. Surg Clin North Am. 2001;81:169–83.PubMedCrossRefGoogle Scholar
  134. 134.
    Williams DR, Coller JA, Corman ML, et al. Anal complications of Crohn’s disease. Dis Colon Rectum. 1981;34:22–4.CrossRefGoogle Scholar
  135. 135.
    Keighley MR, Allan RN. Current status and influence of operation on perianal Crohn’s disease. Int J Colorectal Dis. 1986;1:104–7.PubMedCrossRefGoogle Scholar
  136. 136.
    Buchmann P, Allan R, Thompson H, et al. Carcinoma in rectovaginal fistula in a patient with Crohn’s disease. Am J Surg. 1980;140:462–3.PubMedCrossRefGoogle Scholar
  137. 137.
    Moore-Maxwell CA, Robboy SJ. Mucinous adenocarcinoma arising in rectovaginal fistulas associated with Crohn’s disease. Gynecol Oncol. 2004;93:266–8.PubMedCrossRefGoogle Scholar
  138. 138.
    McCallum DI, Gray WM. Metastatic Crohn’s disease. Br J Dermatol. 1976;95:551–4.PubMedCrossRefGoogle Scholar
  139. 139.
    Acker SM, Sahn EE, Rogers HC, et al. Genital cutaneous Crohn disease. Am J Dermatopathol. 2000;22:443–6.PubMedCrossRefGoogle Scholar
  140. 140.
    Hackzell-Bradely M, Hedblad MA, Stephansson EA. Metastatic Crohn’s disease. Report of 3 cases with special reference to histopathologic findings. Arch Dermatol. 1996;132:928–32.CrossRefGoogle Scholar
  141. 141.
    Becker SW, Kahn D, Rothman S. Cutaneous manifestations of internal malignant tumors. Arch Dermatol. 1942;45:1069–80.CrossRefGoogle Scholar
  142. 142.
    Wilkinson DS. Necrolytic migratory erythema with pancreatic carcinoma. Proc R Soc Med. 1971;64:1197–8.PubMedGoogle Scholar
  143. 143.
    Wilkinson DS. Necrolytic migratory erythema with carcinoma of the pancreas. Trans St Johns Hosp Dermatol Soc. 1973;59:244–50.PubMedGoogle Scholar
  144. 144.
    Wermers RA, Fatourechi V, Wynne AG, et al. The glucagonoma syndrome. Clinical and pathological features in 21 patients. Medicine (Baltimore). 1996;75:53–63.CrossRefGoogle Scholar
  145. 145.
    Lack EE. Pancreatic endocrine neoplasms. In: Lack EE, editor. Pathology of the pancreas, gallbladder, extrahepatic biliary tract and ampullary region. Oxford: Oxford University Press Inc.; 2003. p. 323–72.Google Scholar
  146. 146.
    Eldor R, Glaser B, Fraenkel M, et al. Glucagonoma and the glucagonoma syndrome – cumulative experience with en elusive tumour. Clin Endocrinol (Oxf). 2011;74:593–8.CrossRefGoogle Scholar
  147. 147.
    Soga J, Yakuwa Y. Glucagonomas/diabetic-dermatogenic syndrome (DS): a statistical evaluation of 407 reported cases. J Hepatobiliary Pancreat Surg. 1998;5:312–9.PubMedCrossRefGoogle Scholar
  148. 148.
    Castro PG, de Leon AM, Trancon JG, et al. Glucagonoma syndrome: a case report. J Med Case Reports. 2011;5:402.CrossRefGoogle Scholar
  149. 149.
    Boden G, Owen OE. Familial hyperglucagonemia: an autosomal dominant disorder. N Engl J Med. 1977;296:534–8.PubMedCrossRefGoogle Scholar
  150. 150.
    Kindmark H, Sundin A, Granberg D, et al. Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years. Med Oncol. 2007;24:330–7.PubMedCrossRefGoogle Scholar
  151. 151.
    Mallinson CN, Bloom SR, Warin AP, et al. A glucagonoma syndrome. Lancet. 1974;2:1–5.PubMedCrossRefGoogle Scholar
  152. 152.
    Miller SJ. Nutritional deficiency and the skin. J Am Acad Dermatol. 1989;21:1–30.PubMedCrossRefGoogle Scholar
  153. 153.
    Paterson LL, Shaw JC, Acott KM, et al. Glucagonoma syndrome: in vitro evidence that glucagon increases epidermal arachidonic acid. J Am Acad Dermatol. 1984;11:468–73.CrossRefGoogle Scholar
  154. 154.
    Van Beek AP, de Haas ERM, van Vloten WA, et al. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review. Eur J Endocrinol. 2004;151:531–7.PubMedCrossRefGoogle Scholar
  155. 155.
    Pujol RM, Wang C-YE, el Azhary RA, et al. Necrolytic migratory erythema. Int J Dermatol. 2004;43:12–8.PubMedCrossRefGoogle Scholar
  156. 156.
    Luzar B, Koser-Kola N, Ferlan-Marolt V, et al. A 47-year-old woman with refractory migratory erythema. Clin Exp Dermatol. 2008;33:533–5.PubMedCrossRefGoogle Scholar
  157. 157.
    El Rassi Z, Partensky C, Valette PJ, et al. Necrolytic migratory erythema, first symptom of a malignant glucagonoma: treatment by long-acting somatostatin and surgical resection. Report of three cases. Eur J Surg Oncol. 1998;24:562–7.PubMedCrossRefGoogle Scholar
  158. 158.
    Chiyomaru K, Takai T, Ohashi A, et al. Necrolytic migratory erythema with cholangiocarcinoma: pseudoglucagonoma syndrome. Eur J Dermatol. 2010;20:238–9.PubMedGoogle Scholar
  159. 159.
    Mignogna MD, Fortuna G. Small-cell lung cancer and necrolytic migratory erythema. N Engl J Med. 2008;359:2731–2.PubMedCrossRefGoogle Scholar
  160. 160.
    Möhrenschlager M, Köhler LD, Bruckbauer H, et al. Plattenepithelkarcinom-assoziiertes nekrolytisches migratorisches Erythem. Hautarzt. 1999;50:198–202.PubMedCrossRefGoogle Scholar
  161. 161.
    Walker NPJ. Atypical necrolytic migratory erythema in association with a jejunal adenocarcinoma. J R Soc Med. 1982;75:134–5.PubMedGoogle Scholar
  162. 162.
    Technau K, Renkl A, Norgauer J, et al. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma. Eur J Dermatol. 2005;15:110–2.PubMedGoogle Scholar
  163. 163.
    Koch LH, Lewis DW, Williams JV. Necrolytic migratory erythema-like presentation for cystic fibrosis. J Am Acad Dermatol. 2008;58:29–30.CrossRefGoogle Scholar
  164. 164.
    Kelly CP, Johnston CF, Nolan N, et al. Necrolytic migratory erythema with elevated plasma enteroglucagon in celiac disease. Gastroenterology. 1989;96:1350–3.PubMedGoogle Scholar
  165. 165.
    Bencini PL, Vigo GP, Caputo R. Necrolytic migratory erythema without glucagonoma in a heroin-dependent patient. Dermatology. 1994;189:72–4.PubMedCrossRefGoogle Scholar
  166. 166.
    Muller FM, Arseculerante G, Evans A, et al. Necrolytic migratory erythema in an opiate-dependent patient. Clin Exp Dermatol. 2007;33:40–2.PubMedGoogle Scholar
  167. 167.
    Baricault S, Soubrane JC, Courville P, et al. Necrolytic migratory erythema in Waldmann’s disease. Ann Dermatol Venereol. 2006;133:693–6.PubMedCrossRefGoogle Scholar
  168. 168.
    Topham EJ, Child FJ. Exfoliative erythema of malnutrition with zinc and essential amino acid deficiency. Clin Exp Dermatol. 2005;30:235–7.PubMedCrossRefGoogle Scholar
  169. 169.
    Kitamura Y, Sato M, Hatamochi A, et al. Necrolytic migratory erythema without glucagonoma associated with hepatitis B. Eur J Dermatol. 2005;15:49–51.PubMedGoogle Scholar
  170. 170.
    Trojan A, Jacky E, Follath F, et al. Necrolytic migratory erythema (glucagonoma) – like skin lesions induced by EGF-receptor inhibition. Swiss Med Wkly. 2003;133:22–3.PubMedGoogle Scholar
  171. 171.
    Kheir SM, Omura EF, Grizzle WE, et al. Histological variations in the skin lesions of the glucagonoma syndrome. Am J Surg Pathol. 1996;10:445–53.Google Scholar
  172. 172.
    Hunt SJ, Narus VT, Abell E. Necrolytic migratory erythema: dyskeratotic dermatitis, a clue to early diagnosis. J Am Acad Dermatol. 1991;24:473–7.PubMedCrossRefGoogle Scholar
  173. 173.
    Macbeth AE, James A, Rhodes M, et al. Necrolytic migratory erythema with the absence of necrolysis. Clin Exp Dermatol. 2010;35:810–1.PubMedCrossRefGoogle Scholar
  174. 174.
    Reiter H. Über eine bisher unerkannte Spirochaeteninfektion (Spirochaetosis arthritica). Dtsch Med Wochenschr. 1916;42:1535–6.CrossRefGoogle Scholar
  175. 175.
    Gottlieb NL, Altman RD. An ethical dilemma in rheumatology: should the eponym Reiter’s syndrome be discharged? Semin Arthritis Rheum. 2003;32:207.PubMedCrossRefGoogle Scholar
  176. 176.
    Kwiatkowska B, Filipowicz-Sosnowska A. Reactive arthritis. Pol Arch Med Wewn. 2009;119:60–5.PubMedGoogle Scholar
  177. 177.
    Aho K. Bowel infection predisposing to reactive arthritis. Baillieres Clin Rheumatol. 1989;3:303–19.PubMedCrossRefGoogle Scholar
  178. 178.
    Edmonds J. Reactive arthritis. Aust N Z J Med. 1984;14:81–8.PubMedCrossRefGoogle Scholar
  179. 179.
    Humdulay SS, Glynne SJ, Keat A. When is arthritis reactive? Postgrad Med J. 2006;82:446–53.CrossRefGoogle Scholar
  180. 180.
    Li CW, Ma JJ, Yin J, et al. Reiter’s syndrome in children (abstract). Zhonghua Er Ke Za Zhi. 2010;48:212–5.PubMedGoogle Scholar
  181. 181.
    Bauman C, Cron RQ, Sherry DD, et al. Reiter’s syndrome initially misdiagnosed as Kawasaki disease. J Pediatr. 1996;128:366–9.PubMedCrossRefGoogle Scholar
  182. 182.
    Gladman DD. Clinical aspects of the spondyloarthropathies. Am J Med Sci. 1998;316:234–8.PubMedCrossRefGoogle Scholar
  183. 183.
    Keat A. Reiter’s syndrome and reactive arthritis in perspective. N Engl J Med. 1983;309:1606–15.PubMedCrossRefGoogle Scholar
  184. 184.
    Sampaio-Barros PD, Conde RA, Donadi EA, et al. Frequency of HLA-B27 and its alleles in patients with Reiter syndrome: comparison with frequencies in other spondyloarthropathies and a healthy control population. Rheumatol Int. 2008;28:483–6.PubMedCrossRefGoogle Scholar
  185. 185.
    Taniguchi Y, Yorioka N, Kyuden Y, et al. Reiter’s syndrome associated with HLA-B51: a case report. J Int Med Res. 2003;31:55–7.PubMedGoogle Scholar
  186. 186.
    Rothe MJ, Kerdel FA. Reiter syndrome. Int J Dermatol. 1991;30:173–80.PubMedCrossRefGoogle Scholar
  187. 187.
    Callen JP, Mahl CF. Oculocutaneous manifestations observed in multisystem disorders. Dermatol Clin. 1992;10:709–16.PubMedGoogle Scholar
  188. 188.
    Wu IB, Schwartz R. Reiter’s syndrome: the classic triad and more. J Am Acad Dermatol. 2008;59:113–21.PubMedCrossRefGoogle Scholar
  189. 189.
    Amor B. Reiter’s syndrome: diagnosis and clinical features. Rheum Dis Clin North Am. 1998;24:677–95.PubMedCrossRefGoogle Scholar
  190. 190.
    Willkens RF, Arnett FC, Bitter T, et al. Reiter’s syndrome. Evaluation of preliminary criteria for definite disease. Bull Rheum Dis. 1982;32:31–4.PubMedGoogle Scholar
  191. 191.
    Kozeis N, Trachana M, Tyradellis S. Keratitis in reactive arthritis (Reiter syndrome) in childhood. Cornea. 2011;30:924–5.PubMedCrossRefGoogle Scholar
  192. 192.
    Kim SK, Young J, Park MS, et al. A case of Reiter’s syndrome with progressive myelopathy. J Clin Neurol. 2007;3:215–8.PubMedCrossRefGoogle Scholar
  193. 193.
    Sako SG, Iskander SS, Appel RG. IgA nephropathy and Reiter’s syndrome: report of two cases and review of the literature. Nephron. 2000;84:177–82.CrossRefGoogle Scholar
  194. 194.
    Coskun BK, Saral Y, Ozturk P, et al. Reiter syndrome accompanied by Terry nail. J Eur Acad Dermatol Venereol. 2005;19:87–9.PubMedCrossRefGoogle Scholar
  195. 195.
    Hannu T, Mattila L, Siitonen A, et al. Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis. 2005;64:594–8.PubMedCrossRefGoogle Scholar
  196. 196.
    Uotila T, Antonen J, Laine J, for the Pirkanmaa Waterborne Outbreak Study Group, et al. Reactive arthritis in a population exposed to an extensive waterborne gastroenteritis outbreak after sewage contamination in Pirkanmaa, Finland. Scand J Rheumatol. 2011;40(5):358–62.PubMedCrossRefGoogle Scholar
  197. 197.
    Carter JD, Inman RD, Whittum-Hudson J, et al. Chlamydia and chronic arthritis. Ann Med. 2011; Epub ahead of print.Google Scholar
  198. 198.
    Renou F, Wartel G, Raffray L, et al. Reactive arthritis due to Escherichia coli urinary tract infection. Rev Med Interne. 2011;32:4–5.CrossRefGoogle Scholar
  199. 199.
    Chou YS, Horng CT, Huang HS, et al. Reactive arthritis following Streptococcus viridans urinary tract infection. Ocul Immunol Inflamm. 2010;18:52–3.PubMedCrossRefGoogle Scholar
  200. 200.
    Birnbaum J, Bartlett JG, Gelber AC. Clostridium difficile: an under-recognized cause of reactive arthritis. Clin Rheumatol. 2008;27:253–5.PubMedCrossRefGoogle Scholar
  201. 201.
    Tektonidou MG. Reiter’s syndrome during intravesical BCG therapy for bladder carcinoma. Clin Rheumatol. 2007;26:1368–9.PubMedCrossRefGoogle Scholar
  202. 202.
    Murata H, Adachi Y, Ebitsuka T, et al. Reiter’s syndrome following intravesical bacille Calmette-Guerin treatment for superficial bladder carcinoma: report of six cases. Mod Rheumatol. 2004;14:82–6.PubMedCrossRefGoogle Scholar
  203. 203.
    Thielen AM, Barde C, Janer V, et al. Reiter syndrome triggered by adalimumab (Humira®) and leflunomide (Arava®) in a patient with ankylosing spondylarthropathy and Crohn’s disease. Br J Dermatol. 2007;156:188–9.PubMedCrossRefGoogle Scholar
  204. 204.
    Magro CM, Crowson AN, Peeling R. Vasculitis as the basis of cutaneous lesions in Reiter’s disease. Hum Pathol. 1995;26:633–8.PubMedCrossRefGoogle Scholar
  205. 205.
    International Study Group on Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335:1078–80.Google Scholar
  206. 206.
    O’Neill TW, Rigby AS, Silman AJ, et al. Validation of the International Study Group criteria for Behçet’s disease. Br J Rheumatol. 1994;33:115–7.PubMedCrossRefGoogle Scholar
  207. 207.
    Alpsoy E, Donmez L, Onder M, et al. Clinical features and natural course of Behçet’s disease in 661 cases: a multicentric study. Br J Dermatol. 2007;157:901–6.PubMedCrossRefGoogle Scholar
  208. 208.
    Yiğit O, Alkan S, Başak T, et al. Behçet’s disease presenting with a hypopharyngeal ulcer. Eur Arch Otorhinolaryngol. 2005;262:151–3.PubMedCrossRefGoogle Scholar
  209. 209.
    Webb CJ, Moots RJ, Swift AC. Ear, nose and throat manifestations of Behçet’s disease: a review. J Laryngol Otol. 2008;122:1279–83.PubMedCrossRefGoogle Scholar
  210. 210.
    Jorizzo JL, Abernethy JJ, White WL, et al. Mucocutaneous criteria for the diagnosis of Behçet’s disease: an analysis of clinicopathologic data from multiple international centers. J Am Acad Dermatol. 1995;32:968–76.PubMedCrossRefGoogle Scholar
  211. 211.
    Alpsoy E, Aktekin M, Er H, et al. A randomized, controlled and blinded study of papulopustular lesions in Turkish Behçet’s patients. Int J Dermatol. 1998;17:333–41.Google Scholar
  212. 212.
    Davatchi F, Davatchi F, Shahram F, et al. Behçet’s disease: from east to west. Clin Rheumatol. 2010;29:823–33.PubMedCrossRefGoogle Scholar
  213. 213.
    Mendoza-Pinto C, García-Carrasco M, Jiménez-Hernández M, et al. Etiopathogenesis of Behcet’s disease. Autoimmun Rev. 2010;9:241–5.PubMedCrossRefGoogle Scholar
  214. 214.
    Özen S. Pediatric onset Behcet’s disease. Curr Opin Rheumatol. 2010;22:585–9.PubMedCrossRefGoogle Scholar
  215. 215.
    Calamia KT, Schmirer M, Melikoglu M. Major vessel involvement in Behçet’s disease: an update. Curr Opin Rheumatol. 2011;23:24–31.PubMedCrossRefGoogle Scholar
  216. 216.
    Kapsimali VD, Kanakis MA, Vaiopoulos GA, et al. Etiopathogenesis of Behçet’s disease with emphasis on the role of immunological aberrations. Clin Rheumatol. 2010;29:1211–6.PubMedCrossRefGoogle Scholar
  217. 217.
    Piga M, Mathieu A. Genetic susceptibility to Behçet’s disease: role of genes belonging to the MHC region. Rheumatology. 2011;50:299–310.PubMedCrossRefGoogle Scholar
  218. 218.
    Kone-Paut I, Geisler I, Wechsler B, et al. Familial aggregation in Behçet’s disease: high frequency in siblings and parents of pediatric probands. J Pediatr. 1999;135:89–93.PubMedCrossRefGoogle Scholar
  219. 219.
    Kim B, LeBoit PE. Histopathologic features of erythema nodosum-like lesions in Behçet’s disease: comparison with erythema nodosum, focusing on the role of vasculitis. Am J Dermatopathol. 2000;22:379–90.PubMedCrossRefGoogle Scholar
  220. 220.
    Demirkesen C, Tüzüner N, Mat C, et al. Clinicopathologic evaluation of nodular cutaneous lesions of Behçet’s syndrome. Am J Clin Pathol. 2001;116:341–6.PubMedCrossRefGoogle Scholar
  221. 221.
    Chen K, Kawahara Y, Miyakava S, et al. Cutaneous vasculitis in Behçet’s disease: a clinical and histopathologic study of 20 patients. J Am Acad Dermatol. 1997;36:689–96.PubMedCrossRefGoogle Scholar
  222. 222.
    Chun SI, Su WPD, Lee S. Histopathologic study of cutaneous lesions in Behçet’s disease. J Dermatol. 1990;17:333–41.PubMedGoogle Scholar
  223. 223.
    Serra-Guillen C, Llombart B, Alfaro-Rubio A, et al. Behçet’s disease and periarteritis nodosa with cutaneous lesions. Actas Dermosifiliogr. 2007;98:217–8.PubMedCrossRefGoogle Scholar
  224. 224.
    Liao YH, Hsiao GH, Hsiao CH. Behçet’s disease with cutaneous changes resembling polyarteritis nodosa. Br J Dermatol. 1999;140:368–9.PubMedCrossRefGoogle Scholar
  225. 225.
    Vikas A, Atul S, Singh R, et al. Behçet’s disease with relapsing cutaneous polyarteritis nodosa-like lesions, responsive to oral cyclosporine therapy. Dermatol Online J. 2003;9:9.PubMedGoogle Scholar
  226. 226.
    Heller M. Behçet’s disease (incomplete) and cutaneous polyarteritis nodosa. Dermatol Online J. 2005;11:25.PubMedGoogle Scholar
  227. 227.
    Kalkan G, Karadag AS, Astarci HM, et al. A histopathological approach: when papulopustular lesions should be in the diagnostic criteria of Behçet’s disease? J Eur Acad Dermatol Venereol. 2009;23:1056–60.PubMedCrossRefGoogle Scholar
  228. 228.
    Ergun T, Gürbüz O, Dogusoy G, et al. Histopathologic features of the spontaneous pustular lesions of Behçet’s syndrome. Int J Dermatol. 1998;37:194–6.PubMedCrossRefGoogle Scholar
  229. 229.
    Magro CM, Crowson AN. Sterile neutrophilic folliculitis with perifollicular vasculopathy: a distinctive cutaneous reaction pattern reflecting systemic disease. J Cutan Pathol. 1998;25:215–21.PubMedCrossRefGoogle Scholar
  230. 230.
    Alpsoy E, Uzun S, Akman A, et al. Histological and immunofluorescence findings in non-follicular papulopustular lesions in patients with Behçet’s disease. J Eur Acad Dermatol Venereol. 2003;17:521–4.PubMedCrossRefGoogle Scholar
  231. 231.
    Ilknur T, Pabuççuoglu U, Akin C, et al. Histopathologic and direct immunofluorescence findings of the papulopustular lesions in Behçet’s disease. Eur J Dermatol. 2006;16:146–50.PubMedGoogle Scholar
  232. 232.
    Korman NJ. Bullous pemphigoid: the latest in diagnosis, prognosis and therapy. Arch Dermatol. 1998;134:1137–41.PubMedCrossRefGoogle Scholar
  233. 233.
    Ahmed AR, Newcomer VD. Bullous pemphigoid: clinical features. Clin Dermatol. 1987;5:6–12.PubMedCrossRefGoogle Scholar
  234. 234.
    Kneisel A, Hertl M. Autoimmune bullous skin diseases. Part 1: clinical manifestations. J Dtsch Dermatol Des. 2011;9:844–57.Google Scholar
  235. 235.
    Venning VA, Frith PA, Bron AJ, et al. Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study. Br J Dermatol. 1988;118:7–15.PubMedCrossRefGoogle Scholar
  236. 236.
    Kippes W, Schmidt E, Roth A, et al. Immunopathologic changes in 115 patients with bullous pemphigoid. Hautarzt. 1999;50:866–72.PubMedCrossRefGoogle Scholar
  237. 237.
    Marazza G, Pham HC, Schärer L, for the Autoimmune Bullous Disease Swiss Study Group, et al. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol. 2009;16:861–8.CrossRefGoogle Scholar
  238. 238.
    Farrell AM, Kirtschig G, Dalziel KL, et al. Childhood genital pemphigoid: a clinical and immunopathological study of five patients. Br J Dermatol. 1999;140:308–12.PubMedCrossRefGoogle Scholar
  239. 239.
    Waisbourd-Zinman O, Ben-Amitai D, Cohen AD, et al. Bullous pemphigoid in infancy: clinical and epidemiological characteristics. J Am Acad Dermatol. 2008;58:41–8.PubMedCrossRefGoogle Scholar
  240. 240.
    Fisler RE, Saeb M, Liang MG, et al. Childhood bullous pemphigoid. A clinicopathologic study and review of the literature. Am J Dermatopathol. 2003;25:183–9.PubMedCrossRefGoogle Scholar
  241. 241.
    Nemeth AJ, Klein AD, Gould EW, et al. Childhood bullous pemphigoid: clinical and immunologic features, treatment and prognosis. Arch Dermatol. 1991;127:378–86.PubMedCrossRefGoogle Scholar
  242. 242.
    Mueller S, Klaus-Kovtum V, Stanley JR. A 230-kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol. 1989;9:33–8.CrossRefGoogle Scholar
  243. 243.
    Sawamura D, Li KH, Nomura K, et al. Bullous pemphigoid antigen: cDNA cloning, cellular expression, and evidence for polymorphism of the human gene. J Invest Dermatol. 1991;96:908–15.PubMedCrossRefGoogle Scholar
  244. 244.
    Zillikens D, Giudice GJ. BP180/type XVII collagen: its role in acquired and inherited disorders or the dermal-epidermal junction. Arch Dermatol Res. 1999;291:187–94.PubMedCrossRefGoogle Scholar
  245. 245.
    Kawahara Y, Matsumura K, Hashimoto T, et al. Immunoblot analysis of autoantigens in localized pemphigoid and pemphigoid nodularis. Acta Derm Venereol. 1997;77:187–90.PubMedGoogle Scholar
  246. 246.
    Chan LS, Fine JD, Briggaman RA, et al. Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease. J Invest Dermatol. 1993;101:262–7.PubMedCrossRefGoogle Scholar
  247. 247.
    Mascaró Jr JM, Zillikens D, Giudice GJ, et al. A subepidermal bullous eruption associated with IgG autoantibodies to a 200 kd dermal antigen: the first case report from the United States. J Am Acad Dermatol. 2000;42:309–15.PubMedCrossRefGoogle Scholar
  248. 248.
    Arechalde A, Braun RP, Calza AM, et al. Childhood bullous pemphigoid associated with IgA antibodies against BP180 or BP230 antigens. Br J Dermatol. 1999;140:112–8.PubMedCrossRefGoogle Scholar
  249. 249.
    Collier P, Wojnarowska F, Allen J, et al. Molecular overlap of the IgA target antigens in the subepidermal blistering diseases. Dermatology. 1994;189:105–7.PubMedCrossRefGoogle Scholar
  250. 250.
    Beutner EH, Jordon RE, Chorzelski TP. The immunopathology of pemphigus and pemphigoid. J Invest Dermatol. 1968;51:63–80.PubMedGoogle Scholar
  251. 251.
    Imber MJ, Murphy GF, Jordon RE. The immunopathology of bullous pemphigoid. Clin Dermatol. 1987;5:81–92.PubMedCrossRefGoogle Scholar
  252. 252.
    Provost TT, Tomasi TB. Immunopathology of bullous pemphigoid: basement membrane deposition of IgE, alternative pathway component and fibrin. Clin Exp Immunol. 1974;18:193–200.PubMedGoogle Scholar
  253. 253.
    Ahmed AR, Hombal SM. Cicatricial pemphigoid. Int J Dermatol. 1986;25:90–6.PubMedCrossRefGoogle Scholar
  254. 254.
    Trimarchi M, Bellini C, Fabiano B, et al. Multiple mucosal involvement in cicatricial pemphigoid. Acta Otorhinolaryngol Ital. 2009;29:222–5.PubMedGoogle Scholar
  255. 255.
    Eschle-Meniconi ME, Ahmad SR, Foster CS. Mucous membrane pemphigoid: an update. Curr Opin Ophthalmol. 2005;16:303–7.PubMedCrossRefGoogle Scholar
  256. 256.
    Marran P, Wojnarowska F, Venning V, et al. Vulval involvement in autoimmune bullous disease. J Reprod Med. 1993;38:101–7.Google Scholar
  257. 257.
    Bernard P, Vaillant L, Labeille B, et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous disease French Studying Group. Arch Dermatol. 1995;131:48–52.PubMedCrossRefGoogle Scholar
  258. 258.
    Marren P, Walkden V, Mallon E, et al. Vulval cicatricial pemphigoid may mimic lichen sclerosus. Br J Dermatol. 1996;134:522–4.PubMedCrossRefGoogle Scholar
  259. 259.
    Kharfi M, Khaled A, Anane R, et al. Early onset childhood cicatricial pemphigoid: a case report and review of the literature. Pediatr Dermatol. 2010;27:119–24.PubMedCrossRefGoogle Scholar
  260. 260.
    Schoeffler A, Roth B, Causeret A, et al. Vulvar cicatricial pemphigoid of childhood. Pediatr Dermatol. 2004;21:51–3.PubMedCrossRefGoogle Scholar
  261. 261.
    Hoque SR, Patel M, Farrell AM. Childhood cicatricial pemphigoid confined to the vulva. Clin Exp Dermatol. 2006;31:63–4.PubMedCrossRefGoogle Scholar
  262. 262.
    Bernard P, Prost C, Durepaire N, et al. The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen. J Invest Dermatol. 1992;99:174–9.PubMedCrossRefGoogle Scholar
  263. 263.
    Leverkus M, Bhol K, Hirako Y, et al. Cicatricial pemphigoid with circulating autoantibodies to β4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230. Br J Dermatol. 2001;145:998–1004.PubMedCrossRefGoogle Scholar
  264. 264.
    Tyagi S, Bhol K, Natarajan K, et al. Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci USA. 1996;93:14714–9.PubMedCrossRefGoogle Scholar
  265. 265.
    Ghohestani RF, Nicolas JF, Rouselle P, et al. Identification of a 168-kDa mucosal antigen in a subset of patients with cicatricial pemphigoid. J Invest Dermatol. 1996;107:136–9.PubMedCrossRefGoogle Scholar
  266. 266.
    Smith EP, Taylor TB, Meyer LJ, et al. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid. J Invest Dermatol. 1993;101:619–23.PubMedCrossRefGoogle Scholar
  267. 267.
    Setterfield J, Theron J, Vaughan RW, et al. Mucous membrane pemphigoid: HLD-DQ*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production. Br J Dermatol. 2001;145:406–14.PubMedCrossRefGoogle Scholar
  268. 268.
    Bruch-Gerharz D, Hertl M, Ruzicka T. Mucous membrane pemphigoid: clinical aspects, immunopathological features and therapy. Eur J Dermatol. 2007;17:191–200.PubMedGoogle Scholar
  269. 269.
    Kelly SE, Wojnarowska F. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Br J Dermatol. 1988;118:31–40.PubMedCrossRefGoogle Scholar
  270. 270.
    Bastuji-Garin S, Souissi R, Blum L, et al. Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women. J Invest Dermatol. 1995;104:302–5.PubMedCrossRefGoogle Scholar
  271. 271.
    Joly P, Litrowski N. Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis). Clin Dermatol. 2011;29:432–6.PubMedCrossRefGoogle Scholar
  272. 272.
    Meurer M, Millns JL, Rogers RS, et al. Oral pemphigus vulgaris. Arch Dermatol. 1977;113:1520–4.PubMedCrossRefGoogle Scholar
  273. 273.
    Korman NJ. Pemphigus. Dermatol Clin. 1990;8:689–700.PubMedGoogle Scholar
  274. 274.
    Lim HW, Bystryn J. Bullous diseases. Clin Obstet Gynecol. 1978;21:1007–22.PubMedCrossRefGoogle Scholar
  275. 275.
    Akhyani M, Chams-Davatchi C, Naragi Z, et al. Cevicovaginal involvement in pemphigus vulgaris. Br J Dermatol. 2007;158:478–82.PubMedCrossRefGoogle Scholar
  276. 276.
    Batta K, Munday PE, Tatnall FM. Pemphigus vulgaris localized to the vagina presenting as chronic vulval discharge. Br J Dermatol. 1999;140:945–7.PubMedCrossRefGoogle Scholar
  277. 277.
    Mabrouk D, Razzaque Ahmed A. Analysis of current therapy and clinical outcome in childhood pemphigus vulgaris. Pediatr Dermatol. 2011;28:485–93.PubMedCrossRefGoogle Scholar
  278. 278.
    Becker BA, Gaspari AA. Pemphigus vulgaris and vegetans. Dermatol Clin. 1993;11:429–52.PubMedGoogle Scholar
  279. 279.
    Zaraa I, Sellami A, Bouguerra C, et al. Pemphigus vegetans: a clinical, histological, immunopathological and prognostic study. J Eur Acad Dermatol Venereol. 2011;25:1160–7.PubMedCrossRefGoogle Scholar
  280. 280.
    Amagai M, Karpati S, Prussick R, et al. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest. 1992;90:919–26.PubMedCrossRefGoogle Scholar
  281. 281.
    Ding X, Diaz LA, Fairley JA, et al. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. J Invest Dermatol. 1999;112:739–43.PubMedCrossRefGoogle Scholar
  282. 282.
    Mahoney MG, Wang Z, Rothenberger K, et al. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest. 1999;103:461–8.PubMedCrossRefGoogle Scholar
  283. 283.
    Hashimoto T. Recent advances in the study of the pathophysiology of pemphigus. Arch Dermatol Res. 2003;295:2–11.Google Scholar
  284. 284.
    Sabolinski ML, Beutner EH, Krasny S, et al. Substrate specificity of anti-epithelial antibodies of pemphigus vulgaris and pemphigus foliaceus sera in immunofluorescence tests on monkey and guinea pig esophagus sections. J Invest Dermatol. 1987;88:545–9.PubMedCrossRefGoogle Scholar
  285. 285.
    Sabolinski ML, Beutner EH, Chorzelski TP, et al. Differentiation of pemphigus antibodies of the vulgaris and foliaceus types on monkey and guinea pig esophagus sections. Autoimmunity. 1990;5:229–32.PubMedCrossRefGoogle Scholar
  286. 286.
    Tremeau-Martinage C, Oksman F, Bazex J. Immunoglobulin G subclass distribution of anti-intercellular substance antibodies in pemphigus. Ann Dermatol Venereol. 1995;122:409–11.PubMedGoogle Scholar
  287. 287.
    Hu Z, Bonifas JM, Beech J, et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet. 2000;24:61–5.PubMedCrossRefGoogle Scholar
  288. 288.
    Sudbrak R, Brown J, Dobson-Stone C, et al. Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum Mol Genet. 2000;9:1131–40.PubMedCrossRefGoogle Scholar
  289. 289.
    Richard G, Korge BP, Wright AR. Hailey-Hailey disease maps to a 5cM interval on chromosome 2q21-q24. J Invest Dermatol. 1995;105:357–60.PubMedCrossRefGoogle Scholar
  290. 290.
    Burge SM. Hailey-Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol. 1992;126:275–82.PubMedCrossRefGoogle Scholar
  291. 291.
    Cheng TS, Ho KM, Lam CW. Heterogeneous mutations of the ATP2C1 gene causing Hailey-Hailey disease in Hong Kong Chinese. J Eur Acad Dermatol Venereol. 2010;24:1202–6.PubMedCrossRefGoogle Scholar
  292. 292.
    Schirren H, Schirren CG, Schlüpen EM, et al. Exacerbation of Hailey-Hailey disease by infection with herpes simplex virus. Detection with polymerase chain reaction. Hautarzt. 1995;46:494–7.PubMedCrossRefGoogle Scholar
  293. 293.
    Leyden JJ, Marples RR. Superinfection induced by antibiotics in familial benign chronic pemphigus. Acta Derm Venereol. 1973;53:61–4.PubMedGoogle Scholar
  294. 294.
    Marsch WC, Stuttgen G. Generalized Hailey-Hailey disease. Br J Dermatol. 1978;99:553–60.PubMedCrossRefGoogle Scholar
  295. 295.
    Lyle TW, Knox JM, Richardson JB. Atypical features in benign chronic pemphigus. Arch Dermatol. 1958;78:446–53.CrossRefGoogle Scholar
  296. 296.
    Denis J, Ganansia R, Puy-Montbrun T. Rare anorectal pathologic conditions. Curr Opin Gen Surg. 1994;103–7.Google Scholar
  297. 297.
    Cockayne SE, Rassl DM, Thomas SE. Squamous cell carcinoma arising in Hailey-Hailey disease of the vulva. Br J Dermatol. 1992;142:540–2.CrossRefGoogle Scholar
  298. 298.
    Ochiai T, Honda A, Morishima T, et al. Human papillomavirus types 16 and 39 in a vulval carcinoma occurring in a woman with Hailey-Hailey disease. Br J Dermatol. 1999;140:509–13.PubMedCrossRefGoogle Scholar
  299. 299.
    Chorzelski TP, Kudejko J, Jablonska S. Is papular acantholytic dyskeratosis of the vulva a new entity? Am J Dermatopathol. 1984;6:557–9.PubMedCrossRefGoogle Scholar
  300. 300.
    Coppola G, Muscardin LM, Piazza P. Papular acantholytic dyskeratosis. Am J Dermatopathol. 1986;8:364–5.PubMedCrossRefGoogle Scholar
  301. 301.
    Lee SH, Jang JG. Papular acantholytic dyskeratosis of the genitalia. J Dermatol. 1989;16:312–4.PubMedGoogle Scholar
  302. 302.
    Van Joost TH, Vuzevski VD, Tank B, et al. Benign persistent papular acantholytic and dyskeratotic eruption of vulva. A case report and review of the literature. Br J Dermatol. 1991;124:92–5.PubMedCrossRefGoogle Scholar
  303. 303.
    Bell HK, Farrar CW, Curley RK. Papular acantholytic dermatosis of the vulva. Clin Exp Dermatol. 2001;26:386–8.PubMedCrossRefGoogle Scholar
  304. 304.
    Sáenz AM, Cirocco A, Avendaño M, et al. Papular acantholytic dyskeratosis of the vulva. Pediatr Dermatol. 2005;22:237–9.PubMedCrossRefGoogle Scholar
  305. 305.
    Browne F, Keane H, Walsh M, et al. Papular acantholytic dyskeratosis presenting as genital warts. Int J STD AIDS. 2007;18:867–8.PubMedCrossRefGoogle Scholar
  306. 306.
    Dittmer CJ, Hornemann A, Rose C, et al. Successful laser therapy of a papular acantholytic dyskeratosis of the vulva: case report and review of the literature. Arch Gynecol Obstet. 2010;281:723–5.PubMedCrossRefGoogle Scholar
  307. 307.
    Roh MR, Choi YJ, Lee KG. Papular acantholytic dyskeratosis of the vulva. J Dermatol. 2009;36:427–9.PubMedCrossRefGoogle Scholar
  308. 308.
    Van der Putte SCJ, Oey HB. Papular acantholytic dyskeratosis of the penis. Am J Dermatopathol. 1986;8:365–6.PubMedCrossRefGoogle Scholar
  309. 309.
    Wong TY, Mihm Jr MC. Acantholytic dermatosis localized to the genitalia and crural areas of male patients: a report of three cases. J Cutan Pathol. 1994;21:27–32.PubMedCrossRefGoogle Scholar
  310. 310.
    Warkel RL, Jager RM. Focal acantholytic dyskeratosis of the anal canal. Am J Dermatopathol. 1986;8:362–3.PubMedCrossRefGoogle Scholar
  311. 311.
    Cooper PH. Acantholytic disorders localized to vulvocrural area. J Cutan Pathol. 1998;16:81–4.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Medical FacultyInstitute of Pathology, University of LjubljanaLjubljanaSlovenia
  2. 2.Department of DermatopathologySt. John’s Institute of Dermatology, St. Thomas’ HospitalLondonUK

Personalised recommendations